Guru Ownership Trend
Guru Analysis for Autolus Therapeutics plc (AUTL)
Autolus Therapeutics plc (AUTL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $4.71 M.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.27 M net outflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 39.8%. Conversely, Paul Tudor Jones reduced exposure by 83.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Autolus Therapeutics plc (AUTL)
Major holders include Renaissance Technologies (RenTech) ($3.17 M), Steven Cohen ($589,237), Paul Tudor Jones ($63,774). According to the latest reported data, 3 tracked investment managers collectively hold approximately 2.77 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.27 M, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited AUTL. The total reported sell value was $1.44 M.
Yes, 0 managers opened new positions in AUTL, and 1 increased their existing holdings. The total reported buy value was $167,841.25.